inflammation
EntreMed Inc. (ENMD) Announces Seasoned VP to Assist in Business Development Initiatives
Read the full article: http://blog.qualitystocks.net/?p=10692
EntreMed Inc. (Nasdaq: ENMD) is a pharmaceutical company focused on the development of therapeutic pharmaceutical candidates to treat cancer and inflammation. To reach its goals, the company must maintain an experienced and aggressive management team. EntreMed today announced Thomas H. Bliss will serve as the company’s senior vice president of corporate and business development.
Vested Interest:
The author does not own shares in ENMD- Login or register to post comments
- Email this page
Related Articles
- EntreMed Inc. (ENMD) Announces Seasoned VP to Assist in Business Development Initiatives
- GeoPharma, Inc. (GORX) Adds New Distribution Channels for Mucotrol™ in India, Nepal, Bangladesh, Sri Lanka and South Korea
- Roche offers $43.7B for Genentech
- Biogen Idec Stays Strong with Continued Growth and Development
- Magic Formula Business Sector #2: Healthcare
